Abstract
Introduction Recent studies suggest that omega-3 polyunsaturated fatty acids (PUFAs) supplementation benefits for cardiovascular disease and abdominal aortic aneurysms, but its role in intracranial aneurysms (IAs) remains unclear. This study evaluates the effect of omega-3 PUFAs on IAs.
Patients and methods A two-sample Mendelian Randomization study (MR) was conducted to examine the associations between omega-3 PUFAs and IAs, as well as aneurysmal subarachnoid hemorrhage (aSAH). The largest genome-wide association study dataset was used for primary analysis, with replication using independent sources. Two-step MR was used to evaluate the mediating effects of nine aneurysm risk factors and 91 inflammatory cytokines.
Results Higher genetically predicted levels of total omega-3, omega-3 percentage, and docosahexaenoic acid (DHA) were associated with reduced risks of IAs (combined OR 0.88, 95% CI 0.83-0.94, P<0.001; 0.86, 0.81-0.92, P<0.001; 0.84, 0.78-0.90, P<0.001, respectively) and aSAH (0.85, 0.79-0.91, P=0.009; 0.84, 0.75-0.93, P<0.001; 0.80, 0.71-0.90, P<0.001, respectively). Genetically predicted eicosapentaenoic acid level showed a tendency to increase risk (1.05, 1.01-1.10, P=0.022 for IAs; 1.11, 0.96-1.28, P=0.160 for aSAH). Mediation analysis revealed diastolic blood pressure (DBP) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated DHA’s effects on IAs (proportion mediated 8.5%, P=0.019; 25.2%, P=0.049) and aSAH (5.7%, P=0.024; 27.5%, P=0.041).
Conclusions Our study suggests that omega-3 PUFAs, particularly DHA, are associated with a reduced risk of IAs and aSAH. This association may be partially mediated by DBP and TRAIL.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has been funded by the National Natural Science Foundation of China (No.8217050951, No.82271319), Natural Science Foundation of Beijing Municipality (NO.M22007), Beijing Municipal Science & Technology Commission (Z231100004823009) and R&D Program of Beijing Municipal Education Commission (KM202210025013).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Summary statistics for omega-3 measurements are available through the UK Biobank (application required at https://www.ukbiobank.ac.uk/) and the CHARGE Consortium (https://web.chargeconsortium.com/main/results). Summary statistics for intracranial aneurysms and aneurysmal subarachnoid hemorrhage can be found in the original literature (PMID: 33199917, PMID: 34594039) and the FinnGen database (https://www.finngen.fi/en/access_results). Additionally, summary statistics for the mediators are accessible from the GWAS catalog (https://www.ebi.ac.uk/gwas/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Summary statistics for omega-3 measurements are available through the UK Biobank (application required at https://www.ukbiobank.ac.uk/) and the CHARGE Consortium (https://web.chargeconsortium.com/main/results). Summary statistics for intracranial aneurysms and aneurysmal subarachnoid hemorrhage can be found in the original literature (PMID: 33199917, PMID: 34594039) and the FinnGen database (https://www.finngen.fi/en/access_results). Additionally, summary statistics for the mediators are accessible from the GWAS catalog (https://www.ebi.ac.uk/gwas/).
https://web.chargeconsortium.com/main/results
